Neutropenia and leukemia development: genetic risk factors and prognosis (English)
- New search for: Shahrabi, Saeid
- New search for: Maleknia, Mohsen
- New search for: Tavakolifar, Yousef
- New search for: D. Zayeri, Zeinab
- New search for: Saki, Najmaldin
- New search for: Shahrabi, Saeid
- New search for: Maleknia, Mohsen
- New search for: Tavakolifar, Yousef
- New search for: D. Zayeri, Zeinab
- New search for: Saki, Najmaldin
In:
Leukemia & Lymphoma
;
60
, 14
;
3363-3374
;
2019
- Article (Journal) / Electronic Resource
-
Title:Neutropenia and leukemia development: genetic risk factors and prognosis
-
Contributors:Shahrabi, Saeid ( author ) / Maleknia, Mohsen ( author ) / Tavakolifar, Yousef ( author ) / D. Zayeri, Zeinab ( author ) / Saki, Najmaldin ( author )
-
Published in:Leukemia & Lymphoma ; 60, 14 ; 3363-3374
-
Publisher:
- New search for: Taylor & Francis
-
Publication date:2019-12-06
-
Size:12 pages
-
ISSN:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:English
-
Keywords:
-
Source:
Table of contents – Volume 60, Issue 14
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 3343
-
Biosimilar drugs: how safe are they?Montoto, Silvia et al. | 2019
- 3345
-
Beware of the neutrophil/lymphocyte ratio in diffuse large B-cell lymphomaPorrata, Luis F. et al. | 2019
- 3347
-
For CLL cells, there’s no place like homeLampson, Benjamin L. / Brown, Jennifer R. et al. | 2019
- 3350
-
Immunotherapy for acute myeloid leukemia: from allogeneic stem cell transplant to novel therapeuticsKnorr, David A. / Goldberg, Aaron D. / Stein, Eytan M. / Tallman, Martin S. et al. | 2019
- 3363
-
Neutropenia and leukemia development: genetic risk factors and prognosisShahrabi, Saeid / Maleknia, Mohsen / Tavakolifar, Yousef / D. Zayeri, Zeinab / Saki, Najmaldin et al. | 2019
- 3375
-
Rituximab biosimilar RTXM83 versus reference rituximab in combination with CHOP as first-line treatment for diffuse large B-cell lymphoma: a randomized, double-blind studyCandelaria, Myrna / González, Derlis E. / Delamain, Marcia Torresan / Bär, Daniel Oscar / Beniwal, Surender Kumar / Dasappa, Lokanatha / Flores, David Hugo / Querol, John / Guan, Toh See / Lipatov, Oleg Nikolaevich et al. | 2019
- 3386
-
The neutrophil/lymphocyte ratio ≥3.5 is a prognostic marker in diffuse large B-cell lymphoma: a retrospective analysis from the database of the Italian regional network ‘Rete Ematologica del Lazio per i Linfomi’ (RELLI)Annibali, Ombretta / Hohaus, Stefan / Marchesi, Francesco / Cantonetti, Maria / Di Rocco, Alice / Tomarchio, Valeria / Di Napoli, Arianna / Pelliccia, Sabrina / Battistini, Roberta / Anticoli Borza, Paola et al. | 2019
- 3395
-
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironmentFerrarini, Isacco / Rigo, Antonella / Zamò, Alberto / Vinante, Fabrizio et al. | 2019
- 3406
-
Prognostic factors and nomogram for survival prediction in patients with primary pulmonary lymphoma: a SEER population-based studyLow, Soon Khai / Zayan, Ahmad Helmy / Istanbuly, Obaida / Nguyen Tran, Minh Duc / Ebied, Amr / Mohamed Tawfik, Gehad / Huy, Nguyen Tien et al. | 2019
- 3417
-
Prognostic factors and the impact of frontline therapy in peripheral T-cell lymphoma: 10 years of ‘real-world’ experience from Western AustraliaKuzich, James A. / Hutchison, Andrew P. / Lim, Kenneth J. C. / Smallbone, Portia / Denning, Kate / Wright, Matthew P. / Cull, Gavin / Leahy, Michael F. / Joske, David J. L. / Radeski, Dejan et al. | 2019
- 3426
-
Clinical features and survival of patients with T-cell/histiocyte-rich large B-cell lymphoma: analysis of the National Cancer Data BaseOllila, Thomas A. / Reagan, John L. / Olszewski, Adam J. et al. | 2019
- 3434
-
Prediction of delayed platelet engraftment after autologous stem cell transplantation for B-cell non-Hodgkin lymphomaYamaguchi, Junko / Chinen, Yoshiaki / Takimoto-Shimomura, Tomoko / Nagata, Hiroaki / Muramatsu, Ayako / Kuriyama, Kodai / Ohshiro, Muneo / Hirakawa, Yoshiko / Iwai, Toshiki / Uchiyama, Hitoji et al. | 2019
- 3442
-
Clinical and pathological characteristics of Castleman disease: an observational study in a Spanish tertiary hospitalGonzález-García, Andrés / Patier de la Peña, José Luis / García-Cosio, Mónica / Sarhane, Yasmina / Sánchez Díaz, Cristina / Barbolla Díaz, Ignacio / López Rodríguez, Mónica / Moreno, María Ángeles / Villarubia, Jesús / Manzano, Luis et al. | 2019
- 3449
-
Recognizing severe fatigue and decline in quality of life in Hodgkin lymphoma survivorsTrachtenberg, Estherina / Gurion, Ronit / Mashiach, Tatiana / Tadmor, Tamar / Kedmi, Meirav / Dann, Eldad J. et al. | 2019
- 3455
-
High prevalence of antibiotic allergies in cladribine-treated patients with hairy cell leukemia – lessons for immunopathogenesis and prescribingMeher-Homji, Zaal / Tam, Constantine S. / Siderov, Jim / Seymour, John Francis / Holmes, Natasha E. / Chua, Kyra Y. L. / Phillips, Elizabeth J. / Slavin, Monica A. / Trubiano, Jason A. et al. | 2019
- 3461
-
A multicenter phase 1 study of plerixafor and rituximab in patients with chronic lymphocytic leukemiaAndritsos, Leslie A. / Byrd, John C. / Cheverton, Peter / Wu, Jingyang / Sivina, Mariela / Kipps, Thomas J. / Burger, Jan A. et al. | 2019
- 3470
-
The epidemiological trend of acute promyelocytic leukemia over past four decades: a population-based analysisChen, Ziren / Mai, Wei / Li, Zhengxiong / Zhang, Haoyang / Zheng, Yu / Hong, Shunrong / Yang, Wencong / Xiao, Weiliang / Chen, Zhilin / Wang, Shuncong et al. | 2019
- 3482
-
Phase II trial with sequential clofarabine and cyclophosphamide for refractory and relapsed philadelphia-negative adult acute lymphoblastic leukemia. Results of the GIMEMA LAL 1610 protocolBassan, Renato / Fumagalli, Monica / Chiaretti, Sabina / Audisio, Ernesta / Cascavilla, Nicola / Paolini, Stefania / Delia, Mario / Cerqui, Elisa / Micò, Caterina / Fabbiano, Francesco et al. | 2019
- 3493
-
Safety and efficacy findings from the open-label, multicenter, phase 3b, expanded treatment protocol study of ruxolitinib for treatment of patients with polycythemia vera who are resistant/intolerant to hydroxyurea and for whom no alternative treatments are availableFoltz, Lynda / Pica, Gian-Matteo / Zerazhi, Hacene / Van Droogenbroeck, Jan / Visanica, Sorin / Báez de la Fuente, Enrique / Leber, Brian / de Almeida, Antonio Medina / Ranta, Dana / Kiladjian, Jean-Jacques et al. | 2019
- 3503
-
Occurrence of chromosomal abnormalities in Philadelphia chromosome-negative metaphases in patients with chronic-phase chronic myeloid leukemia undergoing TKI treatmentsSheng, Guangying / Xue, Mengxing / Wang, Qinrong / Wen, Lijun / Chen, Suning / Zhang, Xinyou / Yang, Xiaofei et al. | 2019
- 3512
-
QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropeniaBarreto, Jason N. / Cullen, Michael W. / Mara, Kristin C. / Grove, Meagan E. / Sierzchulski, Amanda G. / Dahl, Nathan J. / Tosh, Pritish K. / Dierkhising, Ross A. / Patnaik, Mrinal M. / Ackerman, Michael J. et al. | 2019
- 3521
-
The effect of melphalan dose and total body irradiation as reduced-intensity conditioning for acute lymphoblastic leukemia patients undergoing allogeneic stem cell transplantationHarada, Kaito / Tachibana, Takayoshi / Ohashi, Kazuteru / Ozawa, Yukiyasu / Sawa, Masashi / Kondo, Tadakazu / Ishikawa, Jun / Onizuka, Makoto / Imada, Kazunori / Fujisaki, Tomoaki et al. | 2019
- 3529
-
HIV portends a poor prognosis in myelodysplastic syndromesKaner, Justin D. / Thibaud, Santiago / Jasra, Sakshi / Wang, Yanhua / Janakiram, Murali / Sharma, Anjali / Sridharan, Ashwin / Elias, Harold / Polineni, Rahul / Assal, Amer et al. | 2019
- 3536
-
Outcomes of autologous hematopoietic cell transplantation in myeloma patients aged ≥75 yearsBashir, Qaiser / Chamoun, Kamal / Milton, Denái R. / Khan, Maliha / Ahmed, Sairah / Mehta, Rohtesh / Popat, Uday R. / Kebriaei, Partow / Nieto, Yago / Oran, Betul et al. | 2019
- 3544
-
Patient-reported outcomes in systemic AL amyloidosis with functional assessment of cancer therapy-general (FACT-G) and patient-reported outcomes measurement information system-global health (PROMIS-GH) in a real-world populationChakraborty, Rajshekhar / Rybicki, Lisa / Tomer, Jacqulyn / Samaras, Christy J. / Faiman, Beth M. / Valent, Jason / Majhail, Navneet S. et al. | 2019
- 3552
-
Increased risk of Hodgkin lymphoma in males with inherited T lymphocyte receptor programed death-1 deficiencyDelamain, Marcia Torresan / Gomez, Gabriela Vilas Bôas / Lourenço, Gustavo Jacob / de Souza, Carmino Antônio / Lima, Carmen Silvia Passos et al. | 2019
- 3557
-
Multicenter evaluation of arsenic trioxide dosing in obese patients with low–intermediate risk acute promyelocytic leukemiaHickey, Erin / Clemons, Bryant / Griffin, Shawn / Cox, Jessica / Sutphin, Stephanie / Ramlal, Reshma / Benitez, Lydia et al. | 2019
- 3561
-
Peripheral T-cell lymphoma NOS arising in patients with classical Hodgkin lymphoma of cytotoxic phenotypeHuettl, Katrin S. / Staiger, Annette M. / Stehle, Alexander / Bonzheim, Irina / Horn, Heike / Borgmann, Vanessa / Ott, Michaela / Fend, Falko / Ott, German et al. | 2019
- 3565
-
Real world Italian experience of pomalidomide plus low-dose dexamethasone in the relapsed and refractory myeloma setting: extended follow-up of a retrospective multicenter study by the ‘Rete Ematologica Pugliese E Basilicata’Mele, Giuseppe / Pastore, Domenico / Di Renzo, Nicola / Fragasso, Alberto / Guarini, Attilio / Mazza, Patrizio / Musto, Pellegrino / Pavone, Vincenzo / Tarantini, Giuseppe / Curci, Paola et al. | 2019
- 3569
-
Patients with diffuse large B-cell lymphoma requiring urgent treatment: its implication on trial design and interpretationLoh, Kah Poh / Baran, Andrea / Lee, Christina Y. / Alshaibani, Alfadel / Rutherford, Sarah C. / Hu, John / Casulo, Carla / Barr, Paul M. / Friedberg, Jonathan W. / Reagan, Patrick M. et al. | 2019
- 3573
-
Response to daratumumab in rituximab-resistant EBV-associated PTLD following allogenic stem cell transplantation from an EBV seronegative donorStrunz, Patrick-Pascal / Schmalzing, Marc / Heidemeier, Anke / Rasche, Leo / Einsele, Hermann / Kortüm, K. Martin et al. | 2019
- 3577
-
Characteristics and outcomes of therapy-related myeloid neoplasms after treatment for multiple myelomaDuong, Vu H. / Holtzman, Noa G. / Koka, Rima / Singh, Zeba N. / Zou, Ying / Emadi, Ashkan / Rapoport, Aaron P. / Kocoglu, Mehmet H. / Baer, Maria R. / Badros, Ashraf Z. et al. | 2019
- 3581
-
Clinical features and cell of origin subtyping using gene expression profiling in HIV-negative patients with primary central nervous system lymphomaHilal, Talal / Maguire, Alanna / Kosiorek, Heidi E. / Rimsza, Lisa M. / Rosenthal, Allison C. et al. | 2019
- 3584
-
‘Secondary chronic myeloid leukemia’: comparison between patients previously exposed or not to chemo- and/or radiotherapyAutore, Francesco / Sorà, Federica / Chiusolo, Patrizia / Annunziata, Mario / Iurlo, Alessandra / Cattaneo, Daniele / Galimberti, Sara / Bajer, Jolanta Alina / Sica, Simona et al. | 2019
- 3587
-
Comparison of circulating tumor DNA between body fluids in patients with primary central nervous system lymphomaWatanabe, Jun / Natsumeda, Manabu / Kanemaru, Yu / Okada, Masayasu / Oishi, Makoto / Kakita, Akiyoshi / Fujii, Yukihiko et al. | 2019
- 3590
-
Ixazomib-induced Sweet's syndromeOka, Satoko / Ono, Kazuo / Nohgawa, Masaharu et al. | 2019